By: Ike Swetlitz, Amber Tong
A US company has tested a brain implant in a Chinese patient in Shanghai, a rare sign of cooperation as the two countries compete to develop the most advanced neurotechnology.
Amber Tong is a Reporter at various esteemed publications including NXTmine and Bloomberg News. She covers critical themes in medicine and healthcare, pharmaceuticals, finance, and trading, focusing on topics such as pharmaceutical manufacturing, regulation, and public health administration. Amber's work has been featured in notable outlets including The Boston Globe, Fortune, and The Irish Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Amber's coverage mainly focuses on healthcare and pharmaceuticals, with a significant emphasis on company announcements and clinical trial outcomes. She appears to be particularly interested in developments within the pharmaceutical industry, including drug development, clinical trials, and company acquisitions.
Given her focus on private sector announcements and press releases, Amber may be more responsive to pitches related to exclusive news from within the pharmaceutical industry or expert insights into major developments such as clinical trial results or company strategies.
It is important to note that Amber does not seem to have a specific geographic focus but rather provides comprehensive coverage of global pharmaceutical industry developments.
This information evolves through artificial intelligence and human feedback. Improve this profile .